Literature DB >> 6774790

Serial studies in von Willebrand's disease: variability versus "variants".

C F Abildgaard, Z Suzuki, J Harrison, K Jefcoat, T S Zimmerman.   

Abstract

The variability of laboratory findings in von Willebrand's disease (vWd) was evaluated by performing serial studies of bleeding time (BT), factor VIII coagulant activity (VIII:C), factor-VIII-related antigen (VIIIR:Ag) and ristocetin cofactor (VIIIR:Rcof) in 50 individuals from 25 families with this disorder. The types of results were characterized from 1 to 16 based on the possible combinations of findings using these four tests. The only patients observed to have consistently abnormal results of all four tests were three individuals with homozygous vWd. Individuals with autosomal dominant vWd were found to have a variety of results and all 16 possible types were observed. Although a consistent pattern was present within some families, others with equivalent history of bleeding demonstrated widely variable types of results. The results within some families, others with equivalent history of bleeding demonstrated widely variable types of results. The results of serial studies of the same tests in 10 normal individuals indicated relative stability, with nearly all values within the usual range of normal, but some independent variation of factor-VIII-related activities was observed. These studies indicate that: (1) the results of BT, VIII:C, VIIIR:Ag, and VIIIR:Rcof vary considerably from time to time in many individuals with vWd, (2) a classification of "variants" of vWd based solely on such studies may be inappropriate, particularly if the tests are not repeated, and (3) repeated testing may be required to establish the diagnosis of vWd in some individuals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774790

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  Translational medicine advances in von Willebrand disease.

Authors:  D Lillicrap
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

2.  The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophilia.

Authors:  M Köhler; P Hellstern; B Reiter; G von Blohn; E Wenzel
Journal:  Klin Wochenschr       Date:  1984-06-01

Review 3.  Haemostasis in hypothyroidism.

Authors:  H C Ford; J M Carter
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

4.  Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease.

Authors:  Junmei Chen; Jesse D Hinckley; Sandra Haberichter; Paula Jacobi; Robert Montgomery; Veronica H Flood; Randall Wong; Gianluca Interlandi; Dominic W Chung; José A López; Jorge Di Paola
Journal:  Blood       Date:  2015-05-27       Impact factor: 22.113

5.  Inheritance and prevalence of von Willebrand's disease severe form in a Brazilian population.

Authors:  R R Fischer; C Lerner; E Bandinelli; A S Fonseca; I Roisenberg
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Simultaneous inheritance and expression of classical haemophilia A and type IIA von Willebrand's disease.

Authors:  A C Beddall; S M Enayat; C E Williams; P E Short; F G Hill
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

7.  Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.

Authors:  M Anvret; M Blombäck; M Lindstedt; E Söderlind; M Tapper-Persson; A C Thelander
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

Review 8.  Current management of von Willebrand's disease.

Authors:  G Castaman; F Rodeghiero
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 9.  Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Association of Hemophilia Clinic Directors of Canada.

Authors: 
Journal:  CMAJ       Date:  1995-07-01       Impact factor: 8.262

Review 10.  Systematic review of sexual function and satisfaction following the management of vaginal agenesis.

Authors:  Sarah K McQuillan; Sonia R Grover
Journal:  Int Urogynecol J       Date:  2014-02-15       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.